Amgen and Dezima Pharma B.V. announced that the companies have entered into a definitive acquisition agreement under which Amgen will...
Ribavirin is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults (see sections 4.2, 4.4, and 5.1). Ribavirin is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) for paediatric patients (children 3 years of age and older and adolescents) not previously treated and without liver decompensation (see sections 4.2, 4.4 and 5.1).
Ribavirin is indicated in combination with other medicinal products except peginterferon alfa-2a and peginterferon alfa-2b, for the treatment of chronic hepatitis C
Teva Pharma UK has launched generic versions of Seroquel and Seroquel XL as Quetiapine and Quetiapine XL.Other generic versions are...
Teva Pharmaceutical Industries Ltd. and Auspex Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement under which...
The FDA has expanded the indication for Azilect (rasagiline tablets), from Teva Pharma, from monotherapy and adjunct to levodopa (LD)...